Biokine
Jerusalem, IL · 1 known investors
BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
Founders & leadership
AP
Amnon PeledCEO/CSO
SC
Simone CabillyChief Scientist
Investors · 1
Frequently asked questions
- What does Biokine do?
- BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
- Who founded Biokine?
- Biokine was founded by Amnon Peled.
- Who are Biokine's investors?
- Biokine's investors include Clal Biotechnology Industries.
- Where is Biokine headquartered?
- Biokine is headquartered in Jerusalem, IL.